Equities

Auxly Cannabis Group Inc

Auxly Cannabis Group Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.05
  • Today's Change-0.01 / -16.67%
  • Shares traded1.61m
  • 1 Year change+233.33%
  • Beta1.2255
Data delayed at least 15 minutes, as of May 13 2024 18:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. The Company's brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company's subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., Auxly Annapolis Inc., Auxly Annapolis OG Inc., and Auxly Leamington Inc.

  • Revenue in CAD (TTM)101.08m
  • Net income in CAD-44.51m
  • Incorporated1987
  • Employees369.00
  • Location
    Auxly Cannabis Group Inc777 Richmond St. W, Unit 002TORONTO M6J 0C2CanadaCAN
  • Phone+1 (647) 812-0121
  • Fax+1 (416) 863-1716
  • Websitehttps://www.auxly.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Helix Biopharma Corp.0.00-5.94m52.75m9.00--80.12-----0.0284-0.02840.000.00290.00----0.00-177.39-261.49----------------0.00------4.16---28.36--
Satellos Bioscience Inc0.00-15.89m52.99m12.00--1.30-----0.1503-0.15030.000.36060.00----0.00-62.93-107.22-72.15-136.58-----------2,598.820.00-------40.33--459.46--
LSL Pharma Group Inc10.03m-8.47m54.10m----4.76--5.39-0.1117-0.11170.12640.105----------------16.40---84.48--0.2053-1.140.6527--------------
Medmira Inc407.78k-2.92m59.91m65.00------146.91-0.0042-0.00420.0006-0.02290.09960.78990.3142---71.41-69.95----61.5466.76-717.02-187.610.1342-2.09-----54.57-5.98-46.08------
Eastwood Bio-Medical Canada Inc736.75k-531.60k60.60m--------82.25-0.0077-0.00770.0107-0.0131.63--38.65---117.75-52.23---140.2960.0052.09-72.15-52.90---227.16-----33.223.13-264.69------
KDA Group Inc186.28k133.66k66.63m--189.054.2976.26357.670.0020.09260.00120.08860.0079--0.0693---0.4146-17.96-0.8534-44.6936.5126.76-52.24-28.00---4.310.1287---22.20-62.03106.88--31.67--
Cannara Biotech Inc73.38m6.22m70.19m--11.230.8855.900.95650.06950.06950.81730.88140.53372.087.46--4.52-4.466.23-4.9510.0617.868.48-15.880.3582-2.460.384--59.91--201.26------
Auxly Cannabis Group Inc101.08m-44.51m75.05m369.00--1.18--0.7425-0.0448-0.04480.1020.05070.34052.246.23273,924.10-14.99-21.47-22.32-24.995.025.08-44.04-124.150.3231-1.590.757--6.99166.8565.84---40.92--
Theratechnologies Inc106.77m-24.60m76.30m89.00------0.7146-0.8469-0.84693.27-0.73141.031.897.81---23.78-26.32-128.23-55.4374.1065.90-23.04-38.261.03-0.9191.71--2.1312.5849.28---37.83--
ZYUS Life Sciences Corp351.00k-42.59m78.61m2.00--3.40--223.97-0.639-0.6390.00580.32630.00660.05770.8069---80.10-57.88-108.06-71.1948.72-16.16-12,134.19-10,367.370.5547-4.560.2979--17.79213.99-72.73------
Data as of May 13 2024. Currency figures normalised to Auxly Cannabis Group Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.